ACLARIS THERAPEUTICS INC. - COMMON STOCK

2,1800

14-ноября-24 16:45:00

15 мин. задержка

Акции

-0,2600

-10,66%

Сегодняшний диапазон

2,1800 - 2,4700

ISIN

N/A

Источник

NASDAQ

Aclaris Therapeutics Completes Enrollment in its Phase 2a Clinical Trial of ATI-1777 for Moderate to Severe Atopic Dermatitis

15 мар 2021 07:00:01 Источник Nasdaq GlobeNewswire
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

25 фев 2021 07:00:04 Источник Nasdaq GlobeNewswire
Aclaris Therapeutics to Participate in Upcoming Investor Conferences

22 фев 2021 07:00:00 Источник Nasdaq GlobeNewswire
Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

10 фев 2021 07:00:00 Источник Nasdaq GlobeNewswire
Aclaris Announces Pricing of Public Offering of Common Stock

20 янв 2021 08:45:00 Источник Nasdaq GlobeNewswire
Aclaris Announces Proposed Public Offering of Common Stock

19 янв 2021 16:01:00 Источник Nasdaq GlobeNewswire
Aclaris Therapeutics Announces Positive Preliminary Topline Data from 12-Week Phase 2a Trial of Oral ATI-450 for Moderate to Severe Rheumatoid Arthritis

19 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.